Targeted Transduction Via CD4 by a Lentiviral Vector Uses a Clathrin-mediated Entry Pathway
Overview
Affiliations
We recently developed a novel targeting Sindbis virus envelope pseudotyped lentiviral vector, 2.2ZZ, which acquires specific transduction capacity by antibody conjugation and binding with specific antigens on the surface of targeted cells. Here we characterize the virological properties of this vector by examining its targeting to CD4 antigen. Our results show that entry is dependent on CD4 cell surface density and occurs via the clathrin-mediated endocytic pathway. These findings provide insight into the mechanism of infection by a new viral vector with combined properties of Sindbis virus and lentiviruses and infectivity conferred by monoclonal antibody-ligand interactions.
Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms.
Michels A, Ho N, Buchholz C Mol Ther. 2022; 30(7):2401-2415.
PMID: 35598048 PMC: 9263322. DOI: 10.1016/j.ymthe.2022.05.018.
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells.
Huckaby J, Landoni E, Jacobs T, Savoldo B, Dotti G, Lai S J Immunother Cancer. 2021; 9(9).
PMID: 34518288 PMC: 8438880. DOI: 10.1136/jitc-2021-002737.
Genetic in vivo engineering of human T lymphocytes in mouse models.
Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J Nat Protoc. 2021; 16(7):3210-3240.
PMID: 33846629 DOI: 10.1038/s41596-021-00510-8.
Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes.
Frank A, Buchholz C Mol Ther Methods Clin Dev. 2018; 12:19-31.
PMID: 30417026 PMC: 6216101. DOI: 10.1016/j.omtm.2018.10.006.
Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules.
Situ K, Chua B, Bae S, Meyer A, Morizono K Virology. 2018; 525:170-181.
PMID: 30290312 PMC: 6269213. DOI: 10.1016/j.virol.2018.09.017.